Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults

By Setyawan Juliana   Hodgkins Paul   Guérin Annie   Gauthier Geneviève   Cloutier Martin   Wu Eric   Erder M. Haim  

Journal of Medical Economics, Vol. 16, Iss. 10, 2013-10 ,pp. : 1203-1215

Informa Healthcare

Access to resources Recommend Favorite

Post‐Injection Delirium/Sedation Syndrome after Olanzapine Long‐Acting Intramuscular Injection – Who is at Risk?

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 3, 2015-09 ,pp. : 213-214

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term use of ciclosporin in a real‐world setting

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 6, 2015-06 ,pp. : 1483-1484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia

By Witte Michael M.   Case Michael G.   Schuh Kory J.   Ascher-Svanum Haya  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 315-323

Informa Healthcare

Access to resources Recommend Favorite

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

By Olivares J. M.   Peuskens J.   Pecenak J.   Resseler S.   Jacobs A.   Akhras K. S.  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2197-2206

Informa Healthcare

Access to resources Recommend Favorite